• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
PENG Shiyan, CHEN Hua, YIN Jie. Determination of azide genotoxic impurity in linezolid API and glucose injection by UPLC-MS/MS[J]. Journal of China Pharmaceutical University, 2022, 53(6): 705-709. DOI: 10.11665/j.issn.1000-5048.20220609
Citation: PENG Shiyan, CHEN Hua, YIN Jie. Determination of azide genotoxic impurity in linezolid API and glucose injection by UPLC-MS/MS[J]. Journal of China Pharmaceutical University, 2022, 53(6): 705-709. DOI: 10.11665/j.issn.1000-5048.20220609

Determination of azide genotoxic impurity in linezolid API and glucose injection by UPLC-MS/MS

Funds: This study was supported by the Discipline Construction Funding Project of National Medical Products Administration Key Laboratory for Quality Research and Evaluation of Chemical Drugs (No. 1030050090124)
More Information
  • Received Date: July 03, 2022
  • Revised Date: November 24, 2022
  • A UPLC-MS/MS method was established for the determination of the genotoxic impurity (R)-5-(azidomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxazolidinone in linezolid API and its glucose injection. Chromatographic separation was performed on a Waters Acquity UPLC HSS T3 column (100 mm × 2.1 mm, 1.8 μm) with 0.1% formic acid water-0.1% formic acid acetonitrile (60∶40) at a flow rate of 0.3 mL/min. The UPLC-MS/MS was equipped with electrospray ionization in positive ionization mode and multiple reaction monitoring mode. The results showed that the calibration curve was linear in the range of 4-12 ng/mL and the limit of quantification was 0.073 ng/mL.The average recoveries of the low, medium and high concentration (80%,100%,120% limit concentration) loading solutions were 101.14%, 100.59% and 101.47%, respectively (RSDs:0.73%, 1.10% and 0.91%, respectively).The sample solution was stable for 6 d.No genotoxic impurity of (R)-5-(Azidomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxazolidinonewas not detected in the samples of linezolid API and its glucose injection.
  • [1]
    . Med Mal Infect,2005,35(9):427-434.
    [2]
    Brickner SJ,Hutchinson DK,Barbachyn MR,et al. Synthesis and antibacterial activity of U-100592 and U-100766,two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections[J]. J Med Chem,1996,39(3):673-679.
    [3]
    European Medicines Agency. ICH guideline M7(R1) on assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk-step 5[EB/OL].(2018-03-02)[2022-04-27]. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-m7r1-assessment-control-dna-reactive-mutagenic-impurities-pharmaceuticals-limit_en.pdf.
    [4]
    Tuberculosis branch of Chinese Medical Association,Expert consensus writing group on linezolid anti-tuberculosis treatment. Expert consensus on anti-tuberculosis treatment with linezolid[J]. Chin J Tuberc Respir Dis(中华结核和呼吸杂志),2018,41(1):14-19.

Catalog

    Article views (134) PDF downloads (336) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return